News

Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Chemomab Presentation at H.C. Wainwright 27th Annual Global Investment Conference ...

Early Season Results Reveal Shifts in How Consumers Are Shopping for Back-to-School Supplies This Year, Circana Reports

Season-to-date, the average selling price of office and school supplies is up 1% from last year, and unit sales volume is down 3%. Season-to-date, store brands (private label) gained market share, ...

Valitor Announces Upcoming Presentations at the Ophthalmology Futures Retina Forum and Euretina Conference, Including New Data for its Long-Acting Anti-VEGF Drug Candidate for ...

New non-human primate (NHP) data for VLTR-559, a long-acting anti-VEGF therapy that could reduce the dosing frequency for the treatment of wet ...

Summit Nanotech Announces In-House Demonstration Plant in Santiago to Accelerate Commercial Lithium Projects

Set to commence customer brine processing in January 2026, the Santiago demonstration plant will receive tanker deliveries of up to 30 m 3 of brine and deliver an asset-specific commercial design ...

Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference

Presentation Details Cantor Global Healthcare Conference Date: Friday, September 5, 2025 Time: 8:00 a.m. – 8:30 a.m. EDT Presenter: Daniel Passeri, Chief Executive Officer Webcast Link: https://stream ...

Cube Biotech and X-Chem Partner to Enable DNA-encoded Library Screening of NativeMP™-stabilized Membrane Proteins

Cube Biotech, a pioneer in membrane protein stabilization and purification, and X-Chem, the global leader in DNA-Encoded Library (DEL) technology and data-driven drug discovery, are proud to announce ...

GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs: COYY, TSYY, NVYY, XBTY, TQQY and YSPY

New York, Aug. 21, 2025 (GLOBE NEWSWIRE) -- GraniteShares today announced the weekly distributions for its GraniteShares YieldBOOST ETFs: COYY, TSYY, NVYY, XBTY, TQQY and YSPY, as shown in the table ...

Beacon Therapeutics Announces EURETINA 2025 Presentations on 9+-Month Phase 2 DAWN and 36-Month Phase 2 SKYLINE Trial Data for laru-zova in Patients with X-linked Retinitis ...

Presentation title : Subretinal gene therapy laru-zova for X-linked retinitis pigmentosa (XLRP): Phase 2 DAWN trial, preliminary month 9+ results Date : Thursday, September 4, 2025 Presenter : Rajiv ...

VeonGen Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for VG801 Gene Therapy for Stargardt Disease

With this milestone, VG801 now holds RMAT, Rare Pediatric Disease, and Orphan Drug designations. VeonGen has also been selected to collaborate with the FDA under the Rare Disease Endpoint Advancement ...

Advent Technologies and Global Semiconductor & Wireless Technology Company Sign Agreement for Ion Pair Membrane Development for Gas Sensing

Dr. Emory De Castro, PhD, Advent’s Chief Technology Officer, stated, “The ability to produce a gas sensor on a chip offers an array of possibilities including the addition of sensing capabilities to ...

Bitcoin Depot Named One of America’s Greatest Companies 2025 by Newsweek

ATLANTA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Bitcoin Depot (“Bitcoin Depot” or the “Company”) (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced that ...

CUSIP Request Volumes for New Corporate Securities Increase in July

Requests for international equity CUSIPs rose 5.5% in July and international debt CUSIP requests rose 22.1%. On an annualized basis, international equity CUSIP requests were up 24.4% and international ...